Skip to content

PHARMACIE NEUJEAN

Active Private limited companyfounded 2002active for 24 yearsPlace Xavier-Neujean 13, 4000 LiègeKBO/BCE: BE 0476.517.844 subsidiary of

Lifetime

20 annual accounts with figures on one time axis, 24 filings since 2002
peak of €301,583 in 2023
€279,640▼ 3.5%
lowest -€4,899 in 2010
€132,144▼ 11.1%
peak of €334,148 in 2025
€334,148▲ 0.3%
€415,212▲ 12.7%
peak of 3 FTE in 2008
1.5 FTE▲ 7.1%
Board6 names since 2013
1 director
Owners
99.89%
Documentsfilings and deeds
12-06-202649 days before the deadline
2025financial year
Dividend €101,036Investments €18,528Cash from €120,653 to €69,693

Key points

from the 2025 annual accounts

Equity

€334,148 ▲ 0.3%
333,0402024+132,144Profit-101,036Dividend-30,000Other334,1482025

PHARMACIE NEUJEAN paid out €101,036 in dividends. That is 76% of the 2025 profit.

Investments

€18,528 3.4 times depreciation
202120222025

Green is investment, beige is depreciation. Machinery stands 82.4% higher than in 2024.

Filings

24 annual accounts since 2002
AprilJune31 JulyOctober20102020

Two of the last ten came late. The 2019 accounts came in latest, 3 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 31,389 companies had the same profile as PHARMACIE NEUJEAN has now. Each dot stands for 79 companies, two years later.

93.4%
were still trading
6.0%
stopped another way
0.5%
went bankrupt
  • Micro
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 31,389 companies, not a prediction for PHARMACIE NEUJEAN. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director,
  • 99.89%equity €883,877 (2025) · annual accounts 2025 of
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0476517844
Company renamed from PHARMACIE BAYARD to PHARMACIE NEUJEAN reappointed as director · acts as permanent representative · Legal-form conversion: from coöperatieve vennootschap met beperkte aansprakelijkheid to private limited company · General meeting of 16-11-2022 · Gazette deed
appointed as sole director acts as permanent representative · Board meeting of 20-07-2019 · Gazette deed
1 director appointed, 3 resignations , and resign · appointed as sole director · acts as permanent representative · General meeting of 01-07-2019 · Gazette deed
All 37 events

Comparable companies

same main activity, similar in size and age
Company
PHARMACIE NEUJEAN Liège €749,360 €279,640 44.6% 1.5
APOTHEEK DRIE KONINGEN Antwerp €673,205 €302,052 53.1% 1.5
D’hONDT FARMA Hamme (Vl.) €776,363 €319,076 76.8% 1.4
PHARMACIE JOLIBOIS-DELAIVE Nandrin €689,206 €300,892 71.3% 1.4
PHARMACIE GHISBAIN Seraing €762,816 €255,668 87.0% 1.9
APOTHEEK OPWIJK LENAERTS Opwijk €697,583 €273,194 14.4% 1.8
NB PHARMA Nieuwpoort €745,538 €272,272 77.0% 1.8

These companies have the same main activity as PHARMACIE NEUJEAN: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €673,000 and €776,000, founded between 1999 and 2006.

Official details

Source: KBO
Status
Active since 10-01-2002Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730
Joint committee
313Pharmacies and pricing offices · annual accounts 2025
Establishment unit
2.098.771.8754000 Liège, since 01-02-2002
Financial year end
31 December
Peppol
Reachable since 13-11-2025
Company details

Annual accounts 2025

≈ €960,000estimated
€749,360▲ 6.8%
Employeeson 31-12-2025
3=
Filing
Filed on 12-06-2026, 49 days before the end of the filing period
Financials

Insights on PHARMACIE NEUJEAN

PHARMACIE NEUJEAN has existed since 2002. The gross margin grew from €161,328 in 2006 to €279,640 in 2025, while staff fell from 2.7 to 1.5 full-time equivalents.

holds all the shares.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about PHARMACIE NEUJEAN

What is the company number of PHARMACIE NEUJEAN?
The company number of PHARMACIE NEUJEAN is 0476.517.844. The VAT number is the same number with BE in front: BE 0476.517.844.
Where is PHARMACIE NEUJEAN based?
The registered office is at Place Xavier-Neujean 13, 4000 Liège.Company details
What does PHARMACIE NEUJEAN do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of PHARMACIE NEUJEAN?
PHARMACIE NEUJEAN is a private limited company (BV).
When was PHARMACIE NEUJEAN founded?
PHARMACIE NEUJEAN was founded on 10-01-2002.
Is PHARMACIE NEUJEAN still active?
Yes, PHARMACIE NEUJEAN is an active enterprise in the KBO register.
How many employees does PHARMACIE NEUJEAN have?
PHARMACIE NEUJEAN had an average of 1.5 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does PHARMACIE NEUJEAN fall under?
In its 2025 annual accounts, PHARMACIE NEUJEAN states joint committee 313 (Pharmacies and pricing offices).
What is the turnover of PHARMACIE NEUJEAN?
The turnover in financial year 2025 is ≈ €960,000. This figure is estimated from the gross margin of €279,640 and 42 comparable companies (NACE 477). It probably lies between €760,000 and €1.3m.
Is PHARMACIE NEUJEAN profitable?
In financial year 2025, PHARMACIE NEUJEAN made a profit of €132,144.
Where can I find the annual accounts of PHARMACIE NEUJEAN?
PHARMACIE NEUJEAN filed 24 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of PHARMACIE NEUJEAN due?
PHARMACIE NEUJEAN must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.